Altamira Therapeutics Ltd.: xbrl:AccrualsClassifiedAsCurrent
| Value | {"amount": 2137730, "currency": "USD"} |
|---|---|
| Period | (as of 2023-01-01) |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/9c139a1c-75c1-4fb3-9ead-ce70c66de189
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-037199Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/9c139a1c-75c1-4fb3-9ead-ce70c66de189
History
- no predecessors — first report